Treating Acute MI Patients With Aggrastat on Their Way to Hospital

Acute Myocardial Infarction Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00300833
• Other study ID #: Aggrastat in AMI.CTIL
• Status: Recruiting
• Phase: Phase 4
• First received: March 1, 2006
• Last updated: August 10, 2011
• Start date: January 2006

Study information

• Verified date: January 2009
• Source: The Baruch Padeh Medical Center, Poriya
• Contact: Yonathan Hasin, Professor
• Phone: 97246652648
• Email: yhasin[@]poria.health.gov.il
• Is FDA regulated: No
• Health authority: Israel: Israeli Health Ministry Pharmaceutical Administration
• Study type: Interventional

Clinical Trial Summary

Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

• women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Myocardial Infarction

Intervention

Drug:
• Tirofiban
pci

Locations

Country	Name	City	State
Israel	Cardiovascular Division, The Baruch Padeh Medical Center, Poriya,	Tiberias
Israel	Magen David ,	Tiberias

Sponsors (1)

Lead Sponsor	Collaborator
The Baruch Padeh Medical Center, Poriya

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mortality		immidiately	No
Secondary	TIMI flow	feeling better	24 hours	No